AURO-LEVETIRACETAM 250 levetiracetam 250 mg tablets Bottle

Country: Ástralía

Tungumál: enska

Heimild: Department of Health (Therapeutic Goods Administration)

Virkt innihaldsefni:

levetiracetam, Quantity: 250 mg

Fáanlegur frá:

Strides Pharma Science Pty Ltd

INN (Alþjóðlegt nafn):

Levetiracetam

Lyfjaform:

Tablet, film coated

Samsetning:

Excipient Ingredients: purified talc; magnesium stearate; povidone; colloidal anhydrous silica; maize starch; titanium dioxide; hypromellose; indigo carmine; macrogol 4000

Stjórnsýsluleið:

Oral

Einingar í pakka:

60, 30

Gerð lyfseðils:

(S4) Prescription Only Medicine

Ábendingar:

It is indicated for:,? use in epileptic patients aged 4 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation,,? monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy.,? add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy (JME),and,? add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (IGE).

Vörulýsing:

Visual Identification: Blue, oval shaped, biconvex film-coated tablets debossed with a deep break line separating 'E' and '10' on one side and plain on the other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Leyfisstaða:

Licence status A

Leyfisdagur:

2011-12-23